Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-07

Clinical Trial Update: Study on the Safety of Abatacept in Relapsing Polychondritis [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety of abatacept in relapsing polychondritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Relapsing Polychondritis | Phase 1 | Status: COMPLETED